Akshay Athreya

Akshay Athreya practices at VCU Medical Center in Richmond, Virginia, part of Commonwealth of Virginia.

Akshay Athreya's NPI, 1962988865, was assigned on July 13, 2018. Akshay Athreya holds Virginia license 0101278832.

Akshay Athreya's primary practice is VCU Medical Center, at 1250 East Marshall Street, Richmond, VA 23298 in Richmond City. The practice phone is (804) 828-9000.

Akshay Athreya's primary practice is VCU Medical Center in Richmond, Virginia, part of Commonwealth of Virginia. Akshay Athreya is also affiliated with Sheltering Arms Institute. The medical group on file is MCV Physicians. Dmand AI also links Akshay Athreya to 2 more hospitals, 1 group practice or clinic and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Akshay Athreya practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Akshay Athreya's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Akshay Athreya is licensed in Virginia.

CMS data shows 1,352 Medicare services from Akshay Athreya across 5 procedure codes in 2024, for 367 Medicare patients. Medicare paid $104,613 for them.

CMS counts 367 Medicare patients who saw Akshay Athreya in 2024. The largest group is under 65, with 166 patients. 75% of them have chronic kidney disease, and 75% have diabetes. 24% are also on Medicaid. Their average risk score is 5.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Akshay Athreya's median patient age at 62, with 43% women.

In 2024, Akshay Athreya wrote 4,037 Medicare Part D claims for 495 patients. 80% of them were for generic drugs. CMS names the drug for 3,746 of them, across 56 drugs with 11 or more claims each, at $494,275 in total drug cost. In 2023, CMS named 526 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Akshay Athreya for performance year 2024, reported as part of a group. Akshay Athreya accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Akshay Athreya as offering telehealth.

Dmand AI links 2 papers to Akshay Athreya in 2024. The most frequent topics are Cell-Free Nucleic Acids, Graft Rejection and Kidney Transplantation. Akshay Athreya's most frequent co-author is Gaurav Gupta, MD.

CMS Open Payments shows 4 general payments to Akshay Athreya from 4 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 89% of the total. Vertex Pharmaceuticals Incorporated paid the most, $483.